STAAR Surgical is trading 5.3% down at $21.22, with no reliable company-specific catalyst identified.
- No reliable September 17, 2026 company-specific announcement, earnings update, or analyst action directly explains the decline.
- Recent coverage highlights its September 14 return to profitability and China-led rebound.
- The broader market is rallying, making a market-wide explanation unlikely; the selloff requires re-checking for delayed news.